Starling Oncology, Inc. Increase (Decrease) in Income Taxes
Starling Oncology, Inc. (DFPH) reported Increase (Decrease) in Income Taxes of -$278.00 thousand for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInIncomeTaxes · last filed 2024-11-13
- Starling Oncology, Inc. increase (decrease) in income taxes for the quarter ending 2024-09-30 was -$135.00K, a 184.91% decline year-over-year.
- Starling Oncology, Inc. increase (decrease) in income taxes for the quarter ending 2024-06-30 was -$99.00K, a 2080.00% decline year-over-year.
- Starling Oncology, Inc. increase (decrease) in income taxes for the quarter ending 2024-03-31 was -$44.00K.
- Starling Oncology, Inc. increase (decrease) in income taxes for the quarter ending 2023-09-30 was $159.00K.
| Period end | Increase (Decrease) in Income Taxes 3 month | Increase (Decrease) in Income Taxes 6 month | Increase (Decrease) in Income Taxes 9 month |
|---|---|---|---|
| 2024-09-30 | -$135.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$234.00K derived: sum of 2 quarters · filed 2024-11-13 | -$278.00K 10-Q · filed 2024-11-13 |
| 2024-06-30 | -$99.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$143.00K 10-Q · filed 2024-08-13 | |
| 2024-03-31 | -$44.00K 10-Q · filed 2024-05-14 | ||
| 2023-09-30 | $159.00K 10-Q · filed 2023-11-08 | $164.00K derived: sum of 2 quarters · filed 2023-11-08 | $28.00K derived: sum of 3 quarters · filed 2023-11-08 |
| 2023-06-30 | $5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$131.00K 10-Q · filed 2023-08-09 | |
| 2023-03-31 | -$136.00K 10-Q · filed 2023-05-10 | ||
| 2022-09-30 | -$11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$785.00K derived: sum of 2 quarters · filed 2022-11-09 | -$823.00K 10-Q · filed 2022-11-09 |
| 2022-06-30 | -$774.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$812.00K 10-Q · filed 2022-08-09 | |
| 2022-03-31 | -$38.00K 10-Q · filed 2022-05-10 | ||
| 2021-09-30 | -$823.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$1.67M 10-Q · filed 2022-11-09 | |
| 2021-06-30 | -$850.00K 10-Q · filed 2022-08-09 |